BAKER TISCH CAPITAL GP LLC Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for BAKER TISCH CAPITAL GP LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of BAKER TISCH CAPITAL GP LLC. BAKER TISCH CAPITAL GP LLC is 10% Owner in VIROPHARMA INC ($VPHM) and Director in SYNAGEVA BIOPHARMA CORP ($GEVA) and 10% Owner in Ardea Biosciences, Inc./DE ($IBPI) and Director in SEATTLE GENETICS INC /WA ($SGEN).
Latest Insider Trading Transactions of BAKER TISCH CAPITAL GP LLC
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, IBPI, SGEN, GEVA, VPHM
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 22 2005 | VPHM | VIROPHARMA INC | BAKER TISCH CAPITAL GP LLC | 10% Owner | Option Exercise | P | 109.15 | 41,000 | 4,475,150 | 124,000 | |
Apr 22 2005 | VPHM | VIROPHARMA INC | BAKER TISCH CAPITAL GP LLC | 10% Owner | Option Exercise | P | 109.15 | 28,000 | 3,056,200 | 83,000 | |
Apr 22 2005 | VPHM | VIROPHARMA INC | BAKER TISCH CAPITAL GP LLC | 10% Owner | Option Exercise | P | 2.50 | 10,000 | 25,000 | 556,000 | |
Apr 18 2005 | VPHM | VIROPHARMA INC | BAKER TISCH CAPITAL GP LLC | 10% Owner | Option Exercise | P | 2.50 | 7,000 | 17,500 | 546,000 | |
Apr 14 2005 | VPHM | VIROPHARMA INC | BAKER TISCH CAPITAL GP LLC | 10% Owner | Option Exercise | P | 109.15 | 55,000 | 6,003,250 | 55,000 | |
Apr 12 2005 | VPHM | VIROPHARMA INC | BAKER TISCH CAPITAL GP LLC | 10% Owner | Option Exercise | P | 2.50 | 15,000 | 37,500 | 539,000 | |
Apr 08 2005 | VPHM | VIROPHARMA INC | BAKER TISCH CAPITAL GP LLC | 10% Owner | Option Exercise | P | 2.50 | 3,000 | 7,500 | 462,000 | |
Apr 08 2005 | VPHM | VIROPHARMA INC | BAKER TISCH CAPITAL GP LLC | 10% Owner | Option Exercise | P | 2.50 | 15,000 | 37,500 | 524,000 | |
Apr 08 2005 | VPHM | VIROPHARMA INC | BAKER TISCH CAPITAL GP LLC | 10% Owner | Option Exercise | P | 2.50 | 47,000 | 117,500 | 509,000 | |
Apr 01 2005 | SGEN | SEATTLE GENETICS I ... | BAKER TISCH CAPITAL GP LLC | Director | Buy | P | 4.96 | 1,134 | 5,627 | 17,845 | 16.7 K to 17.8 K (+6.79 %) |
Apr 14 2005 | IBPI | Ardea Biosciences, ... | BAKER TISCH CAPITAL GP LLC | 10% Owner | Buy | P | 3.57 | 141 | 503 | 6,377 | 6.2 K to 6.4 K (+2.26 %) |
Mar 02 2005 | VPHM | VIROPHARMA INC | BAKER TISCH CAPITAL GP LLC | 10% Owner | Option Exercise | P | 2.50 | 32,000 | 80,000 | 459,000 | |
Mar 02 2005 | VPHM | VIROPHARMA INC | BAKER TISCH CAPITAL GP LLC | 10% Owner | Option Exercise | P | 2.50 | 15,000 | 37,500 | 427,000 | |
Mar 02 2005 | VPHM | VIROPHARMA INC | BAKER TISCH CAPITAL GP LLC | 10% Owner | Option Exercise | P | 2.50 | 37,000 | 92,500 | 412,000 | |
Mar 30 2005 | SGEN | SEATTLE GENETICS I ... | BAKER TISCH CAPITAL GP LLC | Director | Buy | P | 4.90 | 622 | 3,047 | 16,711 | 16.1 K to 16.7 K (+3.87 %) |
Mar 30 2005 | SGEN | SEATTLE GENETICS I ... | BAKER TISCH CAPITAL GP LLC | Director | Buy | P | 4.81 | 261 | 1,256 | 16,089 | 15.8 K to 16.1 K (+1.65 %) |
Mar 30 2005 | SGEN | SEATTLE GENETICS I ... | BAKER TISCH CAPITAL GP LLC | Director | Buy | P | 4.90 | 85 | 417 | 15,828 | 15.7 K to 15.8 K (+0.54 %) |
Mar 24 2005 | SGEN | SEATTLE GENETICS I ... | BAKER TISCH CAPITAL GP LLC | Director | Buy | P | 4.96 | 7,442 | 36,909 | 15,743 | 8.3 K to 15.7 K (+89.65 %) |
Mar 24 2005 | SGEN | SEATTLE GENETICS I ... | BAKER TISCH CAPITAL GP LLC | Director | Buy | P | 4.99 | 5 | 25 | 8,301 | 8.3 K to 8.3 K (+0.06 %) |
Mar 24 2005 | SGEN | SEATTLE GENETICS I ... | BAKER TISCH CAPITAL GP LLC | Director | Buy | P | 5.04 | 7,749 | 39,029 | 8,296 | 547 to 8.3 K (+1,416.64 %) |
Mar 24 2005 | SGEN | SEATTLE GENETICS I ... | BAKER TISCH CAPITAL GP LLC | Director | Buy | P | 4.88 | 547 | 2,669 | 547 | 0 to 547 |
Sep 14 2004 | GEVA | SYNAGEVA BIOPHARMA ... | BAKER TISCH CAPITAL GP LLC | Director | Buy | P | 13.32 | 2,626 | 34,978 | 286,835 | 284.2 K to 286.8 K (+0.92 %) |
Sep 14 2004 | GEVA | SYNAGEVA BIOPHARMA ... | BAKER TISCH CAPITAL GP LLC | Director | Buy | P | 13.56 | 2,100 | 28,474 | 284,209 | 282.1 K to 284.2 K (+0.74 %) |
Sep 14 2004 | GEVA | SYNAGEVA BIOPHARMA ... | BAKER TISCH CAPITAL GP LLC | Director | Buy | P | 12.99 | 171 | 2,221 | 282,109 | 281.9 K to 282.1 K (+0.06 %) |
Sep 14 2004 | GEVA | SYNAGEVA BIOPHARMA ... | BAKER TISCH CAPITAL GP LLC | Director | Buy | P | 12.55 | 3,938 | 49,436 | 281,938 | 278 K to 281.9 K (+1.42 %) |
Page: 1